Illumina inc stock.

Illumina is expected to post earnings of $0.40 per share for the current quarter, representing a year-over-year change of -72.4%. Over the last 30 days, the Zacks Consensus Estimate has changed ...9.66. +0.11. +1.15%. Get Illumina Inc (ILMN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.U.S. genetic testing company Illumina was fined a record 432-million-euro ($476 million) by the EU on Wednesday for closing its takeover of cancer test maker Grail before securing EU antitrust ...Stock Information. View current and historic stock prices, analyst information, and more. Financial Information. Download quarterly earnings reports, supplementary data, SEC filings, and more. Corporate Governance. Learn about our governance guidelines, code of ethics, Board of Directors, and more.

Get the latest news and real-time alerts from Illumina, Inc. (ILMN) stock at Seeking Alpha.

Find the latest Illumina, Inc. (ILMN) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Illumina, Inc. (ILMN) Stock Price, Quote, News & Analysis ILMN Illumina, Inc. Stock Price & Overview 62.97K followers $101.95 0.38 ( +0.37%) 4:00 PM 11/30/23 …

Key statistics. On Monday, Illumina Inc (ILMN:NSQ) closed at 94.65, 6.35% above its 52-week low of 89.00, set on Nov 10, 2023. Data delayed at least 15 minutes, as of Nov 27 2023 21:00 GMT. Latest Illumina Inc (ILMN:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.Innovative technologies. At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers.Company profile page for Illumina Inc including stock price, company news, press releases, executives, board members, and contact informationOct 20, 2023 · Illumina, Inc.’s stock is NA in 2023, NA in the previous five trading days and down 41.56% in the past year. Currently, Illumina, Inc. does not have a price-earnings ratio. Illumina, Inc.’s trailing 12-month revenue is $4.5 billion with a -93.8% net profit margin. Year-over-year quarterly sales growth most recently was 1.2%. SAN DIEGO--(BUSINESS WIRE)--Dec. 27, 2016-- Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the company’s presentation at the J.P. Morgan 35 th Annual Healthcare Conference in San Francisco, California, on January 9, 2017. The live webcast is scheduled to begin at 10:30 AM PT and will feature a brief …

Illumina also sells microarrays (about 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. In depth view into ILMN (Illumina) stock including the latest price, news, dividend history, earnings information and …

Illumina releases 2022 Corporate Social Responsibility Report. SAN DIEGO, June 5, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today published its annual Corporate Social Responsibility (CSR) Report, highlighting the company's commitment to human health, and the progress made ...

Illumina, Inc. Stock Price History. Illumina, Inc.’s price is currently down 7.17% so far this month. During the month of November, Illumina, Inc.’s stock price has reached a high of $118.38 and a low of $89.00. Over the last year, Illumina, Inc. has hit prices as high as $238.55 and as low as $89.00. Year to date, Illumina, Inc.’s stock ...October 11, 2023. SAN DIEGO, Oct. 11, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) posted a stewardship-focused presentation for investors on the Events & Presentations section of its investor relations website, investor.illumina.com, on Wednesday, October 11, 2023. Members of Illumina's Board of Directors and senior …UBS Cuts Illumina Price Target to $111 From $122, Maintains Neutral Rating Nov. 10: MT Canaccord Genuity Downgrades Illumina to Hold From Buy, Adjusts Price Target to $120 From $210 Nov. 10: MT ANALYST RECOMMENDATIONS : Astrazeneca, Biogen, Meta, Netflix, Take-Two, Home Depot...Find the latest Illumina, Inc. (ILMN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo FinanceIllumina, Inc. Common Stock (ILMN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Get the latest Illumina, Inc. (ILMN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Find out the direct holders, institutional holders and mutual fund holders for Illumina, Inc. (ILMN).The average price predicted for Illumina Inc (ILMN) by analysts is $136.31, which is $38.7 above the current market price. The public float for ILMN is 158.12M, and at present, short sellers hold a 3.27% of that float. On November 21, 2023, the average trading volume of ILMN was 2.01M shares. ILMN) stock’s latest price […]Illumina, Inc.’s stock is NA in 2023, NA in the previous five trading days and down 41.56% in the past year. Currently, Illumina, Inc. does not have a price-earnings ratio. Illumina, Inc.’s trailing 12-month revenue is $4.5 billion with a -93.8% net profit margin. Year-over-year quarterly sales growth most recently was 1.2%.Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of California, captioned Kangas v. Illumina, Inc., et al., on behalf of persons and entities that purchased or otherwise acquired Illumina, Inc. (“Illumina” or the “Company”) (NASDAQ: ILMN) …Illumina Inc. closed $136.60 below its 52-week high ($238.55), which the company reached on March 13th. The stock demonstrated a mixed performance when compared to some of its competitors Thursday ...

Illumina releases 2022 Corporate Social Responsibility Report. SAN DIEGO, June 5, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today published its annual Corporate Social Responsibility (CSR) Report, highlighting the company's commitment to human health, and the progress made ...

Best genomics stocks of 2023. Data source: The Motley Fool. Data current as of June 14, 2023. Genomics Company. Market Capitalization. Description. Illumina ( NASDAQ:ILMN ) $32.4 billion. Industry ...Weaker Guidance Dragged Illumina (ILMN) in Q3. (Insider Monkey) Nov-16-23 04:50PM. Illumina: Company Investigated by the Portnoy Law Firm. (GlobeNewswire) 10:15AM. Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors.Hayward Pool Products Inc is a leading manufacturer of high-quality pool equipment, including pumps, filters, heaters, and cleaners. If you’re lucky enough to own one of their products, it’s important to keep it in good condition to ensure ...Stock Information; Corporate Governance; All Investor Information. 25 years of innovation. ... we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. All trademarks are the property ...Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Illumina, Inc. (ILMN) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.9.71. +0.02. +0.21%. Get Illumina Inc (ILMN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2022. February 7, 2023. Revenue of $1.08 billion for Q4 2022, down 10% from Q4 2021, and down 7% on a constant currency basis. Revenue of $4.58 billion for fiscal year 2022, up 1% from fiscal year 2021, and up 3% on a constant currency basis.

Discover historical prices for ILMN stock on Yahoo Finance. View daily, weekly or monthly format back to when Illumina, Inc. stock was issued. ... Illumina, Inc. (ILMN) NasdaqGS - NasdaqGS Real ...

Oct 13, 2023 · Illumina responds to European Commission's divestiture order. SAN DIEGO, Oct. 13, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN), has received an order from the European Commission (EC) directing the company to divest GRAIL. Receipt of the order is an important next step in evaluating divestiture options for GRAIL. Is Illumina Inc stock a buy? Get an edge with ratings and sectors data. Get Report. SIMILAR TO ILMN-Q. ILMN-Q Related Stocks. Symbol, Name. AMGN-Q, Amgen Inc.ILLUMINA INC 0J8Z Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals.Sep 21, 2020 · GRAIL stockholders excluding Illumina will receive approximately 9.9 million Illumina shares if the 20-trading-day volume weighted average price of Illumina stock as of 10 trading days prior to closing is above $399 and approximately 13.4 million Illumina shares if the 20-trading-day volume weighted average price of Illumina stock as of 10 ... 7 hours ago · New York, New York-- (Newsfile Corp. - December 4, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Illumina, Inc. (NASDAQ: ILMN) between May 1, 2023 and October 16, 2023, both dates inclusive (the "Class Period"), of the important January 9, 2024 lead plaintiff deadline. The investigation concerns whether Illumina and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] In 2015, Illumina formed GRAIL, Inc. ("GRAIL") as a corporate subsidiary to develop a blood-based cancer detection test.SAN FRANCISCO, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Illumina, Inc. (NASDAQ: ILMN) investors who suffered substantial losses to submit your losses now. Class Period: May 1, 2023 ...Jul 12, 2023 · Nov 27. Nov 2014 2016 2018 2020 2022 75 100 125 150 175 0 2.5M 5M 7.5M 10M. XNAS:ILMN,NASDAQ:ILMN historical stock data. Stock Date. Stock Price. November 30, 2023. $101.95. November 29, 2023. $101.57. You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.NEW YORK, NY / ACCESSWIRE / December 4, 2023 / If you suffered a loss on your Illumina, Inc. (NASDAQ:ILMN) investment and want to learn about a potential recovery under the federal securities laws ...Nov 30, 2023 · SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2024 - (NASDAQ: ILMN) NEW YORK , Nov. 28, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Illumina, Inc.. Shareholders who purchased shares of ILMN during the ... At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Illumina Inc (ILMN) Stock Price Forecast: Potential Growth and Analyst Consensus. On September 1, 2023, Illumina Inc (ILMN) stock had a median price target of $207.50, according to 20 analysts offering 12-month price forecasts. The high estimate was $318.00, while the low estimate was $135.00. This median estimate represented a …Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of California, captioned Kangas v. Illumina, Inc., et al., on behalf of persons and entities that purchased or otherwise acquired Illumina, Inc. (“Illumina” or the “Company”) (NASDAQ: ILMN) …Jacob Thaysen, PhD is Illumina’s Chief Executive Officer. He joined the company and Board of Directors in September 2023. Prior to Illumina, Jacob was senior vice president of Agilent and president of Agilent's Life Sciences and Applied Markets Group (LSAG) which consists of Agilent's market leading analytical instrument portfolio, informatics and cell …Instagram:https://instagram. portfolio performance trackerfavorite dog breed 2023replimune stockequity trust co custodian THE LAWSUIT: A class action securities lawsuit was filed against Illumina, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between May 1, 2023 and October 16, 2023. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) … brokerage optionsautomated trading software Get the latest Illumina, Inc. (ILMN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.June 11, 2023. SAN DIEGO, June 11, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its Board of Directors has accepted the resignation of Francis deSouza as Illumina's Chief Executive Officer and as a Director, effective Sunday, June 11. fha loans md See Illumina, Inc. (ILMN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Nov 29, 2023 · Delivering Value to Investors. A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, microbiology, and other emerging segments. We are dedicated to improving human health by unlocking the power of the genome.